| Consolidated Cash Flow Statement in summary |
January–December |
| MSEK |
2007 |
2006 |
| Profit before income taxes |
2,662 |
3,173 |
| adjustments for non-cash items and other |
120 |
110 |
| Income tax paid |
–410 |
–1,732 |
| Cash flow from operating activities before changes in working capital |
2,372 |
1,551 |
| Cash flow from changes in working capital |
–45 |
–216 |
| Net cash from operating activities |
2,327 |
1,335 |
| Investing activities |
|
|
| acquisition of property, plant and equipment* |
–541 |
–304 |
| proceeds from sale of property, plant and equipment |
1,165 |
100 |
| acquisition of intangible assets |
–68 |
–270 |
| acquisition of subsidiaries, net of cash acquired |
–1,209 |
–29 |
| divestment of business operations |
– |
31 |
| Changes in financial receivables etc. |
112 |
–60 |
| Changes in current investments |
51 |
277 |
| Net cash used in investing activities |
–490 |
–255 |
| Financing activities |
|
|
| Changes in loans |
1,802 |
3,129 |
| dividends |
–664 |
–627 |
| Repurchase of own shares |
–2,575 |
–3,674 |
| Stock options exercised |
122 |
94 |
| Other |
–111 |
–86 |
| Net cash used in financing activities |
–1,426 |
–1,164 |
| Net increase/decrease in cash and cash equivalents |
410 |
–85 |
| Cash and cash equivalents at the beginning of the period |
3,042 |
3,325 |
| Effect of exchange rate fluctuations on cash and cash equivalents |
–13 |
–198 |
| Cash and cash equivalents at the end of the period |
3,439 |
3,042 |
| * Includes investments held for sale and biological assets |
|
|
| Consolidated statement of recognized income and expense |
January–December |
| MSEK |
2007 |
2006 |
| actuarial gains and losses related to pensions, incl. payroll tax* |
–57 |
44 |
| available-for-sale financial assets |
– |
–40 |
| Cash flow hedges |
38 |
– |
| Translation difference in foreign operations |
–258 |
–867 |
| Tax on items taken to/transferred from equity |
–5 |
–27 |
| Total transactions taken to equity |
–282 |
–891 |
| Net profit for the period recognized in the income statement |
2,056 |
2,335 |
| Total income and expense recognized for the period |
1,773 |
1,443 |
| Attributable to: |
|
|
| Equity holders of the parent |
1,772 |
1,443 |
| Minority interests |
1 |
1 |
| Total income and expense recognized for the period |
1,773 |
1,443 |
| * actuarial gains and losses are calculated at the end of the fourth quarter |
|
|